Correlation of ApoE gene polymorphism with acute myocardial infarction and aspirin resistance after percutaneous coronary intervention
- PMID: 35702102
- PMCID: PMC9185036
Correlation of ApoE gene polymorphism with acute myocardial infarction and aspirin resistance after percutaneous coronary intervention
Abstract
Objective: To determine the correlation of Apolipoprotein E (ApoE) gene polymorphism with acute myocardial infarction (AMI) and aspirin (APC) resistance after percutaneous coronary intervention (PCI).
Methods: In this randomized controlled trial (The Second People's Hospital of Lianyungang Ethics Committee No.L1719), a total of 120 AMI patients admitted to the Second People's Hospital of Lianyungang from January 2019 to June 2020 were enrolled into the research group (Res group) and 120 healthy individuals during the same time period into the control group (Con group). ApoE gene polymorphism was detected by gene microarray and analyzed statistically. The occurrence of APC resistance after PCI was recorded, and the relationship between ApoE gene polymorphism and APC resistance was analyzed.
Results: The Res group showed a significantly lower level of ε3/ε3 gene and significantly higher levels of ε3/ε4 and ε4/ε4 genes than the Con group (all P<0.05), but no notable difference was found in the distribution of ApoE ε2 between the two groups (P>0.05). ApoE ε3 carriers were the main carriers in both groups. However, the Res group showed a lower frequency of ApoE ε3 and a higher frequency of ApoE ε4 compared to the Con group (both P<0.05), and patients with more severe AMI had a significantly higher frequency of ApoE ε4 genotype (P<0.05). According to logistic regression analysis, carrying ApoE ε4 allele (ε3/ε4, ε4/ε4) was a risk factor for AMI (P<0.05). Additionally, patients with APC resistance had a significantly higher frequency of ApoE ε4 allele than those without it (P<0.05). A higher frequency of ApoE ε4 allele was also a risk factor of APC resistance in AMI patients after PCI, and its adjusted risk ratio (OR) was 2.26 times (P<0.05). Moreover, no significant difference was observed among patients with different ApoE genotypes in the incidence of adverse events (P>0.05).
Conclusion: ApoE gene polymorphism is correlated with AMI and APC resistance after PCI, and ApoE ε4 genotype is probably the risk allele for AMI.
Keywords: Apolipoprotein E; acute myocardial infarction; aspirin resistance; polymorphism.
AJTR Copyright © 2022.
Conflict of interest statement
None.
Similar articles
-
Relationship Between Genetic Polymorphism and Cognitive Impairment in Patients with Acute Ischemic Stroke (APOE).Altern Ther Health Med. 2024 Nov;30(11):92-97. Altern Ther Health Med. 2024. PMID: 38401103
-
Association Study of Apolipoprotein E Gene Polymorphism With Incidence and Delayed Resolution of Hemifacial Spasm.Front Neurol. 2021 Dec 15;12:760126. doi: 10.3389/fneur.2021.760126. eCollection 2021. Front Neurol. 2021. PMID: 34975724 Free PMC article.
-
Influence of apolipoprotein E gene polymorphisms on coronary artery disease in patients undergoing coronary angiography.Heliyon. 2024 Jun 26;10(13):e33690. doi: 10.1016/j.heliyon.2024.e33690. eCollection 2024 Jul 15. Heliyon. 2024. PMID: 39040314 Free PMC article.
-
Association of apolipoprotein E genotypes with lipid levels and coronary risk.JAMA. 2007 Sep 19;298(11):1300-11. doi: 10.1001/jama.298.11.1300. JAMA. 2007. PMID: 17878422 Review.
-
The association of apolipoprotein E (APOE) gene polymorphisms with atherosclerosis susceptibility: a meta-analysis.Minerva Cardioangiol. 2016 Feb;64(1):47-54. Epub 2015 May 25. Minerva Cardioangiol. 2016. PMID: 26005211 Review.
Cited by
-
Serum 5'-Nucleotidase as a Novel Predictor of Adverse Clinical Outcomes after Percutaneous Coronary Intervention in Patients with Coronary Artery Disease.Rev Cardiovasc Med. 2024 Jan 10;25(1):17. doi: 10.31083/j.rcm2501017. eCollection 2024 Jan. Rev Cardiovasc Med. 2024. PMID: 39077643 Free PMC article.
-
DNA methylation profile in the whole blood of acute coronary syndrome patients with aspirin resistance.J Clin Lab Anal. 2023 Jan;37(1):e24821. doi: 10.1002/jcla.24821. Epub 2022 Dec 22. J Clin Lab Anal. 2023. PMID: 36550638 Free PMC article.
References
-
- Flora GD, Nayak MK. A brief review of cardiovascular diseases, associated risk factors and current treatment regimes. Curr Pharm Des. 2019;25:4063–4084. - PubMed
-
- Gulati R, Behfar A, Narula J, Kanwar A, Lerman A, Cooper L, Singh M. Acute myocardial infarction in young individuals. Mayo Clin Proc. 2020;95:136–156. - PubMed
-
- Ruiz JR, Labayen I, Ortega FB, Moreno LA, Gonzalez-Lamuno D, Marti A, Nova E, Fuentes MG, Redondo-Figuero C, Martinez JA, Sjostrom M, Castillo MJ AVENA Study Group. Birth weight and blood lipid levels in Spanish adolescents: influence of selected APOE, APOC3 and PPARgamma2 gene polymorphisms. The AVENA Study. BMC Med Genet. 2008;9:98. - PMC - PubMed
-
- Vijayan M, Chinniah R, Ravi PM, Sivanadham R, Mosses Joseph AK, Vellaiappan NA, Krishnan JI, Karuppiah B. MTHFR (C677T) CT genotype and CT-apoE3/3 genotypic combination predisposes the risk of ischemic stroke. Gene. 2016;591:465–470. - PubMed
LinkOut - more resources
Full Text Sources
Miscellaneous